<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05028985</url>
  </required_header>
  <id_info>
    <org_study_id>82090011</org_study_id>
    <nct_id>NCT05028985</nct_id>
  </id_info>
  <brief_title>Early COPD for China Pulmonary Health Study Stage II</brief_title>
  <acronym>EC-CPHS</acronym>
  <official_title>A Cohort Study of Early Chronic Obstructive Pulmonary Disease for China Pulmonary Health Study Stage II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>China-Japan Friendship Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Discovery of the pathogenesis and targets in the progression of early chronic obstructive&#xD;
      pulmonary disease&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project is aimed to investigate and explore the heterogeneity during the progression of&#xD;
      Chronic Obstructive Pulmonary Disease (COPD) in the early stage, utilizing the large-scale&#xD;
      population cohort databases (including &quot;China Pulmonary Health study&quot;, &quot;The Cohort Study for&#xD;
      Chronic Obstructive Pulmonary Disease in China&quot; and &quot;Acute Exacerbation of COPD Patient&#xD;
      Registry in China&quot; ), biological sample libraries(including blood, sputum, expiratory air,&#xD;
      bronchoalveolar lavage fluid(BALF), and lung tissue from COPD patients with different stages&#xD;
      and phenotypes), and multi-omics sequencing (including scRNA-seq, metabolomics, proteomics,&#xD;
      and metagenome). We propose to establish a new standard for COPD stages and subtypes. By&#xD;
      analyzing and mining the multi-omics data, it is expected to illustrate the association&#xD;
      between clinical phenotype and molecular, cellular and tissue heterogeneities, thus reveal&#xD;
      biomarkers related to the progression, clinical phenotypes, and prognosis of early-stage COPD&#xD;
      disease.In addition, we will construct different types and stages of COPD animal models for&#xD;
      further mechanism studies, such as the different pathogenic factors, innate and adaptive&#xD;
      immunity, and the airway microbial ecosystem, so that we can discovered more potential&#xD;
      therapeutic target for early-stage COPD. This project can bring a new insight and scientific&#xD;
      evidence for COPD treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>FEV1 annual decline in clinical practice</measure>
    <time_frame>2021.1-2024.12</time_frame>
    <description>FEV1 measured by portable spirometry can reflect the progression of early COPD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>dyspnea symptoms</measure>
    <time_frame>2021.1-2024.12</time_frame>
    <description>Severity of dyspnea is positively correlated with COPD severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of COPD acute exacerbation</measure>
    <time_frame>2021.1-2024.12</time_frame>
    <description>The frequency of COPD acute exacerbation refers to the number of acute exacerbations per year.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>chest imaging changes</measure>
    <time_frame>2021.1-2024.12</time_frame>
    <description>Emphysema and obstruction in small airway will be evaluated by chest computed tomography(CT).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systemic complications</measure>
    <time_frame>2021.1-2024.12</time_frame>
    <description>Whether there are systemic complications is related to the prognosis of patients.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>early COPD patients</arm_group_label>
    <description>younger than 50 years with 10 or more pack-years smoking history and any of these abnormalities: 1) early airflow limitation (post-bronchodilator forced expiratory volume in the first second(FEV1)/forced vital capacity(FVC) &lt; lower limit of normal), 2) compatible CT abnormalities, 3) rapid decline in FEV1 (â‰¥60 ml/yr).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy people</arm_group_label>
    <description>healthy without any disabling, physical, neurological, or mental disease and were excluded living in a nursing home.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      lung tissues, serum, bronchoalveolar lavage fluid, bronchial epithelial cells, sputum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        early COPD patients and healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  younger than 50 years&#xD;
&#xD;
          -  smoking more than 10 pack-years&#xD;
&#xD;
          -  early airflow limitation(post-bronchodilator FEV1/FVC&lt; lower limit of normal)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cancer&#xD;
&#xD;
          -  other respiratory diseases&#xD;
&#xD;
          -  mental illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chen Wang</last_name>
    <role>Study Chair</role>
    <affiliation>Institue of Basic Medical Sciences Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ting Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>China-Japan Friendship Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jing Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institue of Basic Medical Sciences Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huahao Shen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital of Zhejiang University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capital Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yahong Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Weining Xiong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chen Wang</last_name>
    <phone>+86 010 69156477</phone>
    <email>cyh-birm@263.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HuaHao Shen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ting Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institue of Basic Medical Sciences Chinese Academy of Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yahong Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital, Shanghai JiaoTong university school of medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weining Xiong</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 3, 2021</study_first_submitted>
  <study_first_submitted_qc>August 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2021</study_first_posted>
  <last_update_submitted>August 29, 2021</last_update_submitted>
  <last_update_submitted_qc>August 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China-Japan Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Chen Wang</investigator_full_name>
    <investigator_title>Study Chair</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

